ALAB 10-Q Quarterly Reports

Astera Labs, Inc. reported robust financial performance for the first quarter of 2026, with significant year-over-year growth in revenue and profitability. Revenue more than doubled, reaching $308.4 million, a 93% increase compared to the same period in 2025, driven by strong demand for their Scorpio, Aries, and Taurus products and higher average selling prices. This revenue surge was accompanied by an expansion in gross margin to 76.3%, up from 74.9% in the prior year, attributed to a favorable product mix. Profitability saw substantial improvement, with operating income soaring by 448% to $61.8 million and net income increasing by 152% to $80.3 million. This strong operational performance was underpinned by strategic investments in research and development, which grew by 95% year-over-year, reflecting the company's commitment to innovation in its Intelligent Connectivity Platform. The company ended the quarter with a healthy liquidity position, holding $1.2 billion in cash, cash equivalents, and marketable securities, and generated a strong $74.6 million in cash flow from operations.

Astera Labs, Inc. (ALAB) reported a strong third quarter of 2025, demonstrating significant year-over-year growth. Total revenue surged by 104% to $230.6 million for the three months ended September 30, 2025, and by 128% to $581.9 million for the first nine months of the year, primarily driven by increased unit shipments and a favorable product mix. The company achieved profitability in the current quarter and year-to-date, a significant turnaround from the previous year. This operational improvement is underpinned by robust demand for its Intelligent Connectivity Platform, serving hyperscalers and AI infrastructure needs. Despite increased operating expenses related to headcount growth and R&D initiatives, the company's strategic investments appear to be paying off, with a healthy increase in operating income and a positive net income of $91.1 million for the quarter.

Astera Labs, Inc. reported strong revenue growth in its fiscal second quarter of 2025, with a significant 150% increase year-over-year, driven by higher unit shipments and average selling prices across its Aries, Scorpio, and Taurus product lines. Despite this impressive top-line performance, the gross margin saw a slight decrease due to a shift in product mix towards hardware modules. The company also experienced a substantial increase in operating expenses, primarily due to growth in headcount and R&D initiatives aimed at supporting business expansion and product development. Financially, Astera Labs moved from a net loss in the prior year's comparable period to a substantial net income of $51.2 million for the quarter. This turnaround is further highlighted by the positive net cash provided by operating activities, a significant improvement from the previous year. The company maintains a strong liquidity position with over $1 billion in cash, cash equivalents, and marketable securities, which management believes is sufficient for at least the next 12 months. However, the report also notes material weaknesses in internal control over financial reporting, which the company is actively working to remediate.

Astera Labs, Inc. (ALAB) has reported a strong first quarter for 2025, with a significant 144% year-over-year increase in revenue, reaching $159.4 million. This growth is primarily attributed to higher unit shipments of their Aries and Taurus product lines, coupled with an increased mix of hardware modules contributing to higher average selling prices. Despite the revenue surge, gross margin saw a slight decrease of 250 basis points to 74.9%, mainly due to the aforementioned product mix. The company has also demonstrated a considerable reduction in operating expenses, down 19% year-over-year. This was largely driven by a significant decrease in non-cash stock-based compensation expense following the IPO in the prior year. However, personnel-related expenses increased by 72% due to a substantial rise in headcount, alongside increased investments in research and development. Astera Labs has achieved profitability this quarter with a net income of $31.8 million, a stark contrast to the net loss reported in the same period last year.

Astera Labs, Inc. (ALAB) has reported significant revenue growth in its Q3 2024 10-Q filing, with revenues increasing by 206% year-over-year for the three months ended September 30, 2024, and by 291% for the nine months ended September 30, 2024. This growth is primarily attributed to increased demand for its Aries products and a favorable product mix, including higher-selling second-generation retimers. The company also achieved a substantial improvement in gross margin, reaching 77.7% for both the three and nine-month periods, up from 76.1% and 62.5% in the prior year periods, respectively. This improvement is due to product mix, lower unit costs, and reduced inventory write-downs. Despite the strong revenue and gross profit performance, the company continues to operate at a net loss, reporting a net loss of $7.6 million for the third quarter and $108.1 million for the first nine months of 2024. This is largely driven by substantial increases in operating expenses, particularly R&D and SG&A, which saw significant jumps due to non-cash stock-based compensation expenses related to its IPO, and increased personnel costs from higher headcount. The company's cash position remains robust, bolstered by its March 2024 IPO, with cash, cash equivalents, and marketable securities totaling $886.8 million as of September 30, 2024.

Astera Labs, Inc. reported significant revenue growth in the second quarter of 2024, with revenues reaching $76.9 million, a substantial increase of 619% compared to the same period last year. This growth was primarily driven by strong demand for its Aries products, coupled with an increased mix of higher-priced second-generation products. Despite this revenue surge, the company reported a net loss of $7.5 million for the quarter, although this is an improvement from the $20.0 million net loss in Q2 2023. The company's gross margin remained strong at 77.9% for the quarter. The significant increase in operating expenses, particularly research and development and sales and marketing, is largely attributable to a substantial rise in non-cash stock-based compensation expense following the company's Initial Public Offering (IPO) in March 2024. The company successfully completed its IPO, raising $672.2 million in net proceeds, which significantly bolstered its cash position to $831.0 million in cash, cash equivalents, and marketable securities as of June 30, 2024. Management believes this liquidity is sufficient for at least the next 12 months.

Astera Labs, Inc. (ALAB) reported strong revenue growth in the first quarter of 2024, with revenue increasing 269% year-over-year to $65.3 million, primarily driven by demand for its Aries product and a 20% increase in average selling prices. The company also saw a significant improvement in gross margin, expanding by 53.3 percentage points to 77.4%, attributed to higher selling prices and the absence of a prior year inventory write-down. Despite the impressive top-line growth and margin expansion, Astera Labs continues to operate at a net loss, reporting a net loss of $93.0 million for the quarter. This loss was significantly impacted by increased operating expenses, particularly a substantial rise in stock-based compensation expense related to the company's recent Initial Public Offering (IPO). The company completed its IPO on March 22, 2024, raising $672.2 million in net proceeds. While the company's cash position has strengthened considerably post-IPO, investors should monitor the path to profitability amidst ongoing investments in research and development and sales and marketing.